InvestorsHub Logo
Followers 17
Posts 882
Boards Moderated 0
Alias Born 04/30/2014

Re: None

Saturday, 12/20/2014 1:01:34 PM

Saturday, December 20, 2014 1:01:34 PM

Post# of 721585
Sorry, I posted this as a reply to RK accidentally. It was meant as a general .02 cents comment.

It's difficult for me to see how the results and discussions from this meeting are positive...Dilution to Cognate will continue, and since there is essentially no halt for efficacy, the dilutions will likely continue for another 1.5 years. It appears to me that NWBio is uncertain of the outcome of -L, but are much more confident of -D, so are de-risking the -L trial by the change in trial design and not considering a halt for efficacy, which also gives them time for direct results to mature. I don't think that this is a bad approach in the long term, but short term SP could be bumpy...more of the same :/

I feel for those holding short term options. Though it is true that there are still several short term catalysts that could emerge.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News